Background
Guidelines suggest that patients with non-dysplastic BE undergo endoscopic surveillance every 3–5 years, but actual utilization of surveillance endoscopy and the determinants of variation in surveillance intervals are not known.
Objective
To measure utilization of surveillance endoscopy and its variation in patients with non-dysplastic BE.
Design
Multi-center, cross-sectional study
Setting
Three sites in Arizona, Minnesota, and North Carolina.
Patients
Participants had prevalent BE without a history of high grade dysplasia or EAC.
Interventions
Participants were given validated measures of quality of life, numeracy, and cancer risk perception, and the total number of prior endoscopic surveillance exams was measured.
Main outcome measurements
Over-surveillance was defined as >1 surveillance exam per 3 year period.
Results
Among 235 patients with non-dysplastic BE, 76% were male and 94% Caucasian. The average duration of BE was 6.5 years (± 5.9 years). The mean number of endoscopies per 3 year period was 2.7 (± 2.6 years). Over-surveillance was present in 65% of participants, resulting in a mean of 2.3 excess endoscopies per patient. Neither numeracy skills nor patient perception of cancer risk were associated with over-surveillance.
Limitations
Endoscopies were measured by patient report, which is subject to error. Results may only be generalizable to patients seen in academic centers.
Conclusions
Most patients with non-dysplastic BE had more surveillance endoscopic exams than is recommended by published guidelines. Patient factors did not predict over-surveillance, indicating that other factors may influence decisions about the interval and frequency of surveillance exams.